MTOR and neoplasm: Various agents—such as CSF-1R antagonists, chlorogenic acid, inhibitors targeting mTOR, lipopolysaccharide, curcumin-loaded phytosomes (CCP), and duloxetine—have demonstrated efficacy in redirecting GAMs toward an inflammatory, tumor-suppressive state, thereby mitigating their tumor-supportive properties (94–97).